As of 2026-09-18, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 168.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 151.83 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is 11.3%.
The range of the Relative Valuation is 148.09 - 210.91 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.7x - 30.1x | 26.6x |
| Forward P/E multiples | 24.3x - 27.1x | 24.8x |
| Fair Price | 148.09 - 210.91 | 168.92 |
| Upside | -2.5% - 38.9% | 11.3% |
| Date | P/E |
| 2026-09-16 | 21.31 |
| 2026-09-15 | 21.38 |
| 2026-09-14 | 22.41 |
| 2026-09-11 | 22.26 |
| 2026-09-10 | 22.31 |
| 2026-09-09 | 22.11 |
| 2026-09-08 | 22.11 |
| 2026-09-04 | 22.18 |
| 2026-09-03 | 22.57 |
| 2026-09-02 | 22.49 |
| 2026-09-01 | 22.34 |
| 2026-08-31 | 21.95 |
| 2026-08-28 | 21.96 |
| 2026-08-27 | 22.22 |
| 2026-08-26 | 22.32 |
| 2026-08-25 | 21.86 |
| 2026-08-24 | 21.81 |
| 2026-08-21 | 21.74 |
| 2026-08-20 | 21.80 |
| 2026-08-19 | 22.17 |
| 2026-08-18 | 21.98 |
| 2026-08-17 | 22.02 |
| 2026-08-14 | 21.77 |
| 2026-08-13 | 21.50 |
| 2026-08-12 | 22.30 |
| 2026-08-11 | 23.08 |
| 2026-08-10 | 23.50 |
| 2026-08-07 | 23.29 |
| 2026-08-06 | 22.78 |
| 2026-08-05 | 23.02 |
| 2026-08-04 | 23.67 |
| 2026-08-03 | 23.69 |
| 2026-07-31 | 23.77 |
| 2026-07-30 | 26.44 |
| 2026-07-29 | 25.77 |
| 2026-07-28 | 26.06 |
| 2026-07-27 | 25.14 |
| 2026-07-24 | 25.05 |
| 2026-07-23 | 24.82 |
| 2026-07-22 | 24.61 |
| 2026-07-21 | 25.52 |
| 2026-07-20 | 24.66 |
| 2026-07-17 | 24.35 |
| 2026-07-16 | 24.45 |
| 2026-07-15 | 24.52 |
| 2026-07-14 | 24.52 |
| 2026-07-13 | 24.81 |
| 2026-07-10 | 25.24 |
| 2026-07-09 | 25.73 |
| 2026-07-08 | 25.40 |